FDA Drug · D-0239-2026

Ondansetron ODT Tablets, USP 4mg, 1x10 unit dose tablets, Mfg: Glenmark Pharmaceuticals Limited, Repackaged by Preferred Pharmaceuticals NDC 68788-8666-01

Class II · Ongoing

Defective container: Preferred Pharmaceuticals received a letter from the manufacturer Glenmark, that the blister packs are not fully sealed and tablets falling out. Preferred Pharmaceuticals purchased the finished product and repackaged the product for sale.

Affected lots / codes — check yours against thisLot: J1325J, I1725P, EXP Date: 4/30/2027.

Recalling firm: Preferred Pharmaceuticals, Inc., Anaheim, CA
Classification: Class II (temporary or reversible harm possible)
Status: Ongoing
Quantity: 575 1x10 Foil Blister Packs
Distribution: Natinowide in the USA
Recall initiated: November 17, 2025
Classified: December 17, 2025
Initiation: Voluntary: Firm initiated

Official source. This record is published by the U.S. FDA through the openFDA enforcement database. View the unmodified government record:
https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0239-2026%22

Important. Recalls target specific lots and codes — compare the affected lots above against your own product. This page reproduces public FDA data for readability; EveryRecall is independent and not affiliated with the FDA.

Check this brand across all 8 databases →